Ventas, Inc. – Consensus ‘buy’ rating and 6.4% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Ventas, Inc. with ticker code (VTR) have now 17 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between $61.00 and $49.00 calculating the mean target price we have $52.90. Now with the previous closing price of $49.71 and the analysts are correct then we can expect a percentage increase in value of 6.4%. The day 50 moving average is $45.96 and the 200 day MA is $45.04. The market capitalization for the company is 20.20B. The stock price for the company is currently is currently $49.90 USD

The potential market cap would be $21,494,388,309 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $11.46 and a 1.67% return on assets.

Ventas, Inc. is a real estate investment trust (REIT). The Company is engaged in operating at the intersection of healthcare and real estate. It has a portfolio of senior housing communities, medical office buildings (MOBs), life science, research and innovation centers, hospitals and other healthcare facilities. The Company’s segments include Triple-Net Leased Properties, Senior Housing Operating Portfolio (SHOP), and Office Operations. Triple-Net Leased Properties is engaged in investing in and owning senior housing and healthcare properties throughout the United States and the United Kingdom and leasing those properties to healthcare operating companies under triple-net or absolute-net leases. The Senior Housing Operating Portfolio (SHOP) segment invests in senior housing communities throughout the United States and Canada. The Office Operations segment acquires, owns, develops, leases and manages MOBs and life science, research and innovation centers throughout the United States.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search